Emergence of SGLT2 Inhibitors as Powerful Antioxidants in Human Diseases.

Antioxidants (Basel) · 2021 · PMC8388972 · PMID 34439414

Europe PMC DOI

hedged sentence

0.0539

closest p · 1.1× alpha

0.0539

boldest claim

The sentences

did not reach statistical significancep = 0.0539so close (0.05 < p ≤ 0.1)

The controlled attenuation parameter, a marker of liver steatosis, was significantly reduced by 8% in the dapagliflozin group; however, the improvement in liver stiffness measurement did not reach statistical significance (from 9.49 kPa to 8.01 kPa, p = 0.0539).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.